Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer

This study has been completed.
Sponsor:
Collaborators:
Van Andel Research Institute
Eli Lilly and Company
Battle Creek Health System
Hackley Hospital
Metropolitan Hospital, Michigan
Mecosta County General Hospital
Munson Medical Center
Saint Mary's Health Care
Information provided by:
Spectrum Health Hospitals
ClinicalTrials.gov Identifier:
NCT00202800
First received: September 12, 2005
Last updated: June 3, 2013
Last verified: June 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2011
  Primary Completion Date: September 2007 (Final data collection date for primary outcome measure)